Molecular pathology of low malignant bladder 
transitional cell carcinoma: a current perspective

Publication:
Molecular pathology of low malignant bladder transitional cell carcinoma: a current perspective

dc.contributor.author	Wang, H.T.	es
dc.contributor.author	Chang, J.W.	es
dc.date.accessioned	2011-06-30T11:59:51Z
dc.date.available	2011-06-30T11:59:51Z
dc.date.issued	2005
dc.description.abstract	Bladder transitional cell carcinoma (BTCC) actually has two phenotypes: low malignant and aggressive. Most previous molecular and cytogenetic analyses of bladder cancer were focused on aggressive BTCC. Little is known about the events that lead to the development of low malignant BTCC. This review mainly introduces the concept of two types of bladder tumors and then focuses on the molecular pathology of low malignant BTCC in particular. It is hoped that further understanding of the molecular pathology of low malignant BTCC may provide novel therapies and many other clinical benefits in patients with this disease.	es
dc.format	application/pdf	es
dc.format.extent	7	es
dc.identifier.issn	0213-3911	es
dc.identifier.uri	http://hdl.handle.net/10201/22445
dc.language	eng	es
dc.publisher	Murcia : F. Hernández	es
dc.relation.ispartof	Histology and histopathology	es
dc.rights	info:eu-repo/semantics/openAccess	es
dc.subject	Bladder cancer	es
dc.subject	Oncogene	es
dc.subject.other	CDU::6 - Ciencias aplicadas::61 - Medicina	es
dc.title	Molecular pathology of low malignant bladder transitional cell carcinoma: a current perspective	es
dc.type	info:eu-repo/semantics/article	es
dspace.entity.type	Publication	es

Now showing 1 - 1 of 1

Sin licencia Creative Commons.